Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.

Saved in:

Bibliographic Details
Title:	Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.
Authors:	Thallinger, Christiane^1,2 (AUTHOR), Lang, Istvan³ (AUTHOR), Kuhar, Cvetka Grasic⁴ (AUTHOR), Bartsch, Rupert¹ (AUTHOR), Singer, Christian F⁵ (AUTHOR), Petruzelka, Lubos⁶ (AUTHOR), Melichar, Bohuslav⁷ (AUTHOR), Knittelfelder, Regina² (AUTHOR), Brodowicz, Thomas^1,2 (AUTHOR), Zielinski, Christoph^1,2 (AUTHOR)
Source:	BMC Cancer. 2/18/2016, Vol. 16, p121-121. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	14712407
DOI:	10.1186/s12885-016-2171-y